TYPE2 DIABETES
Clinical trials for TYPE2 DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE2 DIABETES trials appear
Sign up with your email to follow new studies for TYPE2 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a diabetes drug tame blood sugar swings after bariatric surgery?
Disease control ENROLLING_BY_INVITATIONThis phase 2 trial tests whether dapagliflozin, a diabetes drug, can reduce dangerous blood sugar highs and lows in people who have had bariatric surgery. The study will enroll 30 participants, both with and without type 2 diabetes, and monitor glucose levels continuously for 12 …
Matched conditions: TYPE2 DIABETES
Phase: PHASE2 • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
Intense lifestyle overhaul shows promise for new diabetes patients
Disease control OngoingThis study tests whether a 12-week program of very-low-calorie diet or high-intensity exercise can improve blood sugar control in adults aged 40-70 who are newly diagnosed with type 2 diabetes and overweight. Participants are randomly assigned to diet, exercise, or standard educa…
Matched conditions: TYPE2 DIABETES
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
Gene test reveals who benefits from diabetes drug
Knowledge-focused OngoingThis pilot study looks at how the diabetes drug sitagliptin affects people who naturally have lower levels of the DPP4 enzyme due to their genes. Researchers will compare 20 adults with and without this genetic trait to see changes in blood sugar and enzyme activity after a meal.…
Matched conditions: TYPE2 DIABETES
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:09 UTC
-
Massive study reveals best Second-Line diabetes meds for heart and kidney protection
Knowledge-focused OngoingThis study looks at health records from over 780,000 people with type 2 diabetes to compare four common second-line medications: SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas. The goal is to see which drug class is most effective at preventing hea…
Matched conditions: TYPE2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC